` CALC (CalciMedica Inc) vs S&P 500 Comparison - Alpha Spread

C
CALC
vs
S&P 500

Over the past 12 months, CALC has significantly outperformed S&P 500, delivering a return of +54% compared to the S&P 500's +12% growth.

Stocks Performance
CALC vs S&P 500

Loading
CALC
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CALC vs S&P 500

Loading
CALC
S&P 500
Difference
www.alphaspread.com

Performance By Year
CALC vs S&P 500

Loading
CALC
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
CalciMedica Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

CalciMedica Inc
Glance View

Market Cap
61.7m USD
Industry
Pharmaceuticals

CalciMedica, Inc. operates as a biopharmaceutical company. The company is headquartered in La Jolla, California and currently employs 8 full-time employees. The company went IPO on 2020-09-25. The firm is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases. CRAC channels serve to replenish calcium levels in the endoplasmic reticulum (ER) and provide calcium for cellular signaling events. Its lead product candidate, Auxora, is an intravenous-formulated, small molecule CRAC channel inhibitor. Auxora has the capability to modulate the immune response and protect against tissue cell injury, addressing inflammatory diseases, such as acute pancreatitis (AP), asparaginase-associated acute pancreatitis (AAP), acute kidney injury (AKI), and acute hypoxemic respiratory failure.

CALC Intrinsic Value
Not Available
C
Back to Top